Ryanodine receptors (RyR2) regulate intracellular Ca2+ release from the sarcoplasmic reticulum (SR), and are important determinants of cardiac contractility. We have recently demonstrated that the enzyme Ca2+/calmodulin-dependent protein kinase (CaMKII) phosphorylates serine 2814 (S2814) on RyR2, which increases SR Ca2+ release and serves as an important regulatory mechanism to enhance cardiac contractility at faster heart rates. On the other hand, upregulated CaMKII activity has been identified as an important signaling defect in congestive heart failure (CHF). Chronic CaMKII phosphorylation of RyR2 has been proposed as a principal cause of enhanced SR Ca2+ leak, which is an important determinant of contractile dysfunction in CHF. The long-term goal of this project is to define the cellular/molecular mechanisms by which CaMKII regulates RyR2-mediated SR Ca2+ release and cardiac contractility in normal and failing hearts, by studying knockin mice in which the CaMKII phosphorylation site serine 2814 (S2814) on RyR2 is either inactivated (S2814A) or constitutively activated (S2814D). Our hypothesis is that in normal hearts, CaMKII phosphorylates S2814 on RyR2 to increase SR Ca2+ release and cardiac contractility, whereas in failing hearts chronic CaMKII phosphorylation of RyR2-S2814 enhances diastolic leak of Ca2+ from the SR, which interferes with SR Ca2+ loading and causes depressed contractility.
The specific aims are to: 1) Define the effects of CaMKII phosphorylation of RyR2 on cardiac contractility;2) Determine whether chronic CaMKII phosphorylation of RyR2-S2814 is sufficient to induce heart failure;3) Evaluate whether inhibition of CaMKII phosphorylation of RyR2 is therapeutic in heart failure. We propose to conduct multidisciplinary studies ranging from in vivo studies in genetically-altered mice, Ca2+ imaging studies in isolated cardiomyocytes, and biochemical and single channel measurements of RyR2 Ca2+ release channels. It is anticipated that these studies will advance our understanding of CaMKII-dependent mechanisms underlying the regulation of cardiac contractility in both normal and failing hearts. The animal models developed for this project may be particularly useful for the development of new drugs for the treatment of congestive heart failure, the leading cause of death in the United States.

Public Health Relevance

Leaky intracellular calcium release channels are an important determinant of contractile dysfunction in heart failure. We will use genetic mouse models to study how the enzyme calmodulin-dependent kinase regulates the activity of intracellular calcium release channels in healthy and failing hearts. These studies may facilitate the development of new pharmacological approaches for the treatment of heart failure, the leading cause of death in the United States.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL091947-04
Application #
8270566
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Adhikari, Bishow B
Project Start
2009-07-15
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2014-04-30
Support Year
4
Fiscal Year
2012
Total Cost
$379,913
Indirect Cost
$132,413
Name
Baylor College of Medicine
Department
Physiology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Federico, Marilen; Portiansky, Enrique L; Sommese, Leandro et al. (2017) Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance. J Physiol 595:4089-4108
Quick, Ann P; Wang, Qiongling; Philippen, Leonne E et al. (2017) SPEG (Striated Muscle Preferentially Expressed Protein Kinase) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity. Circ Res 120:110-119
Quick, Ann P; Landstrom, Andrew P; Wang, Qiongling et al. (2017) Novel junctophilin-2 mutation A405S is associated with basal septal hypertrophy and diastolic dysfunction. JACC Basic Transl Sci 2:56-67
Klipp, Robert C; Li, Na; Wang, Qiongling et al. (2017) EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Heart Rhythm :
Li, Na; Wang, Qiongling; Sibrian-Vazquez, Martha et al. (2017) Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs. Int J Cardiol 227:668-673
Lezcano, N; Mariángelo, J I E; Vittone, L et al. (2017) Early effects of Epac depend on the fine-tuning of the sarcoplasmic reticulum Ca2+ handling in cardiomyocytes. J Mol Cell Cardiol 114:1-9
Heijman, Jordi; Ghezelbash, Shokoufeh; Wehrens, Xander H T et al. (2017) Serine/Threonine Phosphatases in Atrial Fibrillation. J Mol Cell Cardiol 103:110-120
Liu, Ruya; Lee, Jeongkyung; Kim, Byung S et al. (2017) Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy. JCI Insight 2:
Pham, Khanh; Dong, Jie; Jiang, Xiqian et al. (2017) Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation. Am J Physiol Endocrinol Metab 312:E136-E149
Landstrom, Andrew P; Dobrev, Dobromir; Wehrens, Xander H T (2017) Calcium Signaling and Cardiac Arrhythmias. Circ Res 120:1969-1993

Showing the most recent 10 out of 111 publications